N-imidazolebenzyl-histidine substitution in somatostatin and in its octapeptide analogue modulates receptor selectivity and function

J Med Chem. 2011 Sep 8;54(17):5981-7. doi: 10.1021/jm200307v. Epub 2011 Aug 16.

Abstract

Despite 3 decades of focused chemical, biological, structural, and clinical developments, unusual properties of somatostatin (SRIF, 1) analogues are still being uncovered. Here we report the unexpected functional properties of 1 and the octapeptide cyclo(3-14)H-Cys-Phe-Phe-Trp(8)-Lys-Thr-Phe-Cys-OH (somatostatin numbering; OLT-8, 9) substituted by imBzl-l- or -d-His at position 8. These analogues were tested for their binding affinity to the five human somatostatin receptors (sst(1-5)), as well as for their functional properties (or functionalities) in an sst(3) internalization assay and in an sst(3) luciferase reporter gene assay. While substitution of Trp(8) in somatostatin by imBzl-l- or -d-His(8) results in sst(3) selectivity, substitution of Trp(8) in the octapeptide 9 by imBzl-l- or -d-His(8) results in loss of binding affinity for sst(1,2,4,5) and a radical functional switch from agonist to antagonist.

MeSH terms

  • Cells, Cultured
  • Histidine / chemistry*
  • Humans
  • Imidazoles / chemistry*
  • Immunoenzyme Techniques
  • Luciferases / metabolism
  • Oligopeptides / chemistry*
  • Peptides, Cyclic / chemistry*
  • Radioligand Assay
  • Receptors, Somatostatin / agonists*
  • Receptors, Somatostatin / antagonists & inhibitors*
  • Receptors, Somatostatin / metabolism
  • Somatostatin / analogs & derivatives*
  • Somatostatin / chemistry
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Imidazoles
  • Oligopeptides
  • Peptides, Cyclic
  • Receptors, Somatostatin
  • Histidine
  • Somatostatin
  • Luciferases